Feldman & Pinto’s Philadelphia Invokana Drug Injury Lawyers are evaluating Invokana drug injury cases from people who have suffered harmful Invokana side effects.
Invokana is a diabetes drug manufactured by Janssen Pharmaceuticals to treat type-2 diabetes.
Invokana and other SGLT2 inhibitor drugs lower the level of glucose in a diabetic patient’s blood by encouraging the kidneys’ disposal of glucose through the urine during the kidneys’ blood filtering process. Invokana is linked to increased risks of:
- kidney injury, kidney infection, and renal failure
- heart attack
- leg and foot amputations
- diabetic ketoacidosis
- serious urinary tract infections, and
- bone fractures
Invokana drug injury lawsuits filed against the drug manufacturer allege that the company:
- did not adequately test the safety of Invokana
- knew or should have known of the increased risks associated with Invokana
- failed to adequately warn doctors and consumers of these risks, and
- marketed Invokana for uses not approved by the FDA (off-label marketing)
Invokana and Diabetic Ketoacidosis
Diabetic ketoacidosis is an excess of acid in a patient’s bloodstream that can result in serious complications, including kidney failure, diabetic coma, and death. Diabetic ketoacidosis from Invokana use can cause dehydration. In severe cases, this dehydration can lead to kidney failure. When this occurs, the patient may need dialysis treatments or a transplanted kidney to survive.
The U.S. Food and Drug Administration (FDA) issued a “safety communication” in May 2015 after Invokana was linked to 20 cases of diabetic ketoacidosis. The FDA issued a second safety communication in December 2015 and updated the Invokana label after receiving reports of 73 additional cases of diabetic ketoacidosis.
The FDA warned patients to stop taking Invokana and other SGLT2 inhibitor drugs and seek immediate medical attention if they have any symptoms of ketoacidosis, including:
- abdominal pain
- fatigue, and
- difficulty breathing
Invokana and Kidney Failure
In addition to kidney failure caused by Invokana’s diabetic ketoacidosis effect, Invokana can also cause renal damage in other ways. People with diabetes are already at high risk of chronic kidney disease (CKD) and kidney failure. Invokana’s reliance on the kidneys to release extra sugar through the urine may increase the risk of severe urinary tract infections (UTIs) in the patient. The UTIs can cause further injury to a diabetic patient’s already damaged kidneys, raising the patient’s risk of total renal failure.
Invokana drug injury lawsuits brought against Janssen Pharmaceuticals (and Johnson & Johnson, its parent company) seek damages for consumers’ serious injuries and deaths caused by Invokana.
Feldman & Pinto Philadelphia Medical Malpractice Attorneys also file law suits against medical professionals responsible for their patients’ Invokana injuries and deaths. Doctors who prescribe Invokana for patients at high risk of injury or death from Invokana can be liable for their patients’ Invokana complications. Doctors can also be liable for failing to take reasonable care to watch for and prevent these complications in patients who use Invokana.
Contact a Philadelphia Invokana Drug Injury Lawyer
You may be entitled to money damages if you sustained personal injuries after use of Invokana. Please contact us to learn more about filing an Invokana drug injury lawsuit. Our Philadelphia personal injury attorneys can help you obtain the compensation and justice you deserve.